Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Akili, Inc. Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game June 18, 2024 From Akili, Inc. Via Business Wire Tickers AKLI Akili Reports First Quarter 2024 Financial Results and Provides Business Update May 14, 2024 From Akili, Inc. Via Business Wire Tickers AKLI Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results April 30, 2024 From Akili, Inc. Via Business Wire Tickers AKLI Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update February 29, 2024 From Akili, Inc. Via Business Wire Tickers AKLI Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan February 26, 2024 From Akili, Inc. Via Business Wire Tickers AKLI Akili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updates February 21, 2024 From Akili, Inc. Via Business Wire Tickers AKLI EndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17 December 18, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili Reports Third Quarter 2023 Financial Results and Provides Business Update November 09, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9 at 4:30 p.m. ET October 19, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Employees with ADHD Aren’t Reaching Their Full Potential at Work, Akili Study Finds October 12, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili Announces Leadership Transition October 06, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili Releases EndeavorOTC™ on Android™ Devices, Expanding Treatment Access for Millions of Adults with ADHD September 21, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili Announces Business Transformation, Focusing on Non-prescription Model September 13, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili Reports Second Quarter 2023 Financial Results and Provides Business Update August 10, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 10 at 4:30 p.m. ET July 10, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili Releases EndeavorOTCTM Video Game Treatment to Improve Attention in Adults with ADHD June 07, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili to Present Clinical Data from Pivotal Trial of Video Game Treatment in Adolescents with ADHD at 2023 ASCP Annual Meeting and Elevate Psych Congress May 31, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili Reports First Quarter 2023 Financial Results and Provides Business Update May 11, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic May 03, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 11 at 4:30 p.m. ET April 13, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update March 07, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, March 7 at 4:30 p.m. ET February 06, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili to Participate in the Cowen 43rd Annual Health Care Conference February 02, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference January 06, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Pivotal Trial of EndeavorRxⓇ in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes January 05, 2023 From Akili, Inc. Via Business Wire Tickers AKLI Akili Announces ADHD Expert Dr. Scott Kollins to Join as Chief Medical Officer December 01, 2022 From Akili, Inc. Via Business Wire Tickers AKLI Akili Reports Third Quarter 2022 Financial Results and Company Update November 10, 2022 From Akili, Inc. Via Business Wire Tickers AKLI Financial Industry Veteran Mary Hentges Joins Akili’s Board of Directors October 27, 2022 From Akili, Inc. Via Business Wire Tickers AKLI Akili to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 10 at 4:30 p.m. ET October 19, 2022 From Akili, Inc. Via Business Wire Tickers AKLI Akili Launches EndeavorRx® Expedition - A Direct-to-Patient Product Registry September 21, 2022 From Akili, Inc. Via Business Wire Tickers AKLI Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
